Limits...
CoDiab-VD: protocol of a prospective population-based cohort study on diabetes care in Switzerland.

Zuercher E, Bordet J, Burnand B, Peytremann-Bridevaux I - BMC Health Serv Res (2015)

Bottom Line: For consenting participants, physicians provided few additional pieces of information about processes and laboratory results.The core of the follow-up questionnaires will be similar to the baseline one, with the addition of thematic modules adapting to the development of the PcD.Physicians will be contacted every 2 years.

View Article: PubMed Central - PubMed

Affiliation: Institute of social and preventive medicine (IUMSP), Lausanne University Hospital, Lausanne, Switzerland. Emilie.Zuercher@chuv.ch.

ABSTRACT

Background: Diabetes represents an increasing health burden worldwide. In 2010, the Public Health Department of the canton of Vaud (Switzerland) launched a regional diabetes programme entitled "Programme cantonal Diabète" (PcD), with the objectives to both decrease the incidence of diabetes and improve care for patients with diabetes. The cohort entitled CoDiab-VD emerged from that programme. It specifically aimed at following quality of diabetes care over time, at evaluating the coverage of the PcD within this canton and at assessing the impact of the PcD on care of patients with diabetes.

Methods/design: The cohort CoDiab-VD is a prospective population-based cohort study. Patients with diabetes were recruited in two waves (autumn 2011--summer 2012) through community pharmacies. Eligible participants were non-institutionalised adult patients (≥ 18 years) with diabetes diagnosed for at least one year, residing in the canton of Vaud and coming to a participating pharmacy with a diabetes-related prescription. Women with gestational diabetes, people with obvious cognitive impairment or insufficient command of French were not eligible. Self-reported data collected, included the following primary outcomes: processes-of-care indicators (annual checks) and outcomes of care such as HbA1C, (health-related) quality of life measures (Short Form-12 Health Survey--SF-12, Audit of Diabetes-Dependent Quality of Life 19--ADDQoL) and Patient Assessment of Chronic Illness Care (PACIC). Data on diabetes, health status, healthcare utilisation, health behaviour, self-management activities and support, knowledge of, or participation to, campaigns/activities proposed by the PcD, and socio-demographics were also obtained. For consenting participants, physicians provided few additional pieces of information about processes and laboratory results. Participants will be followed once a year, via a mailed self-report questionnaire. The core of the follow-up questionnaires will be similar to the baseline one, with the addition of thematic modules adapting to the development of the PcD. Physicians will be contacted every 2 years.

Discussion: CoDiab-VD will allow obtaining a broad picture of the care of patients with diabetes, as well as their needs regarding their chronic condition. The data will be used to evaluate the PcD and help prioritise targeted actions.

Trial registration: This study is registered with ClinicalTrials.gov, identifier NCT01902043, July 9, 2013.

Show MeSH

Related in: MedlinePlus

Study design of the CoDiab-VD cohort
© Copyright Policy - OpenAccess
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC4536695&req=5

Fig2: Study design of the CoDiab-VD cohort

Mentions: The CoDiab-VD is a prospective population-based cohort study launched in 2011 in the canton of Vaud/Switzerland, conducted by the Institute of Social and Preventive Medicine (IUMSP) of the Lausanne University Hospital. Baseline data were collected during a two-wave recruitment period in the autumn of 2011 and in the summer of 2012 (Fig. 1). Patients’ follow-ups will be set up yearly (Fig. 2).Fig. 1


CoDiab-VD: protocol of a prospective population-based cohort study on diabetes care in Switzerland.

Zuercher E, Bordet J, Burnand B, Peytremann-Bridevaux I - BMC Health Serv Res (2015)

Study design of the CoDiab-VD cohort
© Copyright Policy - OpenAccess
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC4536695&req=5

Fig2: Study design of the CoDiab-VD cohort
Mentions: The CoDiab-VD is a prospective population-based cohort study launched in 2011 in the canton of Vaud/Switzerland, conducted by the Institute of Social and Preventive Medicine (IUMSP) of the Lausanne University Hospital. Baseline data were collected during a two-wave recruitment period in the autumn of 2011 and in the summer of 2012 (Fig. 1). Patients’ follow-ups will be set up yearly (Fig. 2).Fig. 1

Bottom Line: For consenting participants, physicians provided few additional pieces of information about processes and laboratory results.The core of the follow-up questionnaires will be similar to the baseline one, with the addition of thematic modules adapting to the development of the PcD.Physicians will be contacted every 2 years.

View Article: PubMed Central - PubMed

Affiliation: Institute of social and preventive medicine (IUMSP), Lausanne University Hospital, Lausanne, Switzerland. Emilie.Zuercher@chuv.ch.

ABSTRACT

Background: Diabetes represents an increasing health burden worldwide. In 2010, the Public Health Department of the canton of Vaud (Switzerland) launched a regional diabetes programme entitled "Programme cantonal Diabète" (PcD), with the objectives to both decrease the incidence of diabetes and improve care for patients with diabetes. The cohort entitled CoDiab-VD emerged from that programme. It specifically aimed at following quality of diabetes care over time, at evaluating the coverage of the PcD within this canton and at assessing the impact of the PcD on care of patients with diabetes.

Methods/design: The cohort CoDiab-VD is a prospective population-based cohort study. Patients with diabetes were recruited in two waves (autumn 2011--summer 2012) through community pharmacies. Eligible participants were non-institutionalised adult patients (≥ 18 years) with diabetes diagnosed for at least one year, residing in the canton of Vaud and coming to a participating pharmacy with a diabetes-related prescription. Women with gestational diabetes, people with obvious cognitive impairment or insufficient command of French were not eligible. Self-reported data collected, included the following primary outcomes: processes-of-care indicators (annual checks) and outcomes of care such as HbA1C, (health-related) quality of life measures (Short Form-12 Health Survey--SF-12, Audit of Diabetes-Dependent Quality of Life 19--ADDQoL) and Patient Assessment of Chronic Illness Care (PACIC). Data on diabetes, health status, healthcare utilisation, health behaviour, self-management activities and support, knowledge of, or participation to, campaigns/activities proposed by the PcD, and socio-demographics were also obtained. For consenting participants, physicians provided few additional pieces of information about processes and laboratory results. Participants will be followed once a year, via a mailed self-report questionnaire. The core of the follow-up questionnaires will be similar to the baseline one, with the addition of thematic modules adapting to the development of the PcD. Physicians will be contacted every 2 years.

Discussion: CoDiab-VD will allow obtaining a broad picture of the care of patients with diabetes, as well as their needs regarding their chronic condition. The data will be used to evaluate the PcD and help prioritise targeted actions.

Trial registration: This study is registered with ClinicalTrials.gov, identifier NCT01902043, July 9, 2013.

Show MeSH
Related in: MedlinePlus